You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High Risk Myelodysplastic Syndromes (MDS)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Brasschaat, Belgium
  • +9 more
Jan 19, 2023

MDS Trial in Bronx (Pyrimethamine)

Withdrawn
  • Myelodysplastic Syndromes
  • Bronx, New York
    Montefiore Medical Center
Sep 15, 2021

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Sep 18, 2023

AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

Recruiting
  • AML
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2021

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Hefei, Anhui, China
    • +16 more
    Sep 6, 2022

    Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
    • High-risk Myelodysplastic Syndrome (MDS)
    • Durham, North Carolina
    • +8 more
    Dec 13, 2022

    Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

    Recruiting
    • Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Aug 23, 2022

    Acute Myeloid Leukemia, Adult, MDS Trial in Marseille, Paris, Pierre-Bénite (ABD-3001)

    Active, not recruiting
    • Acute Myeloid Leukemia, Adult
    • Myelodysplastic Syndromes
    • Marseille, France
    • +2 more
    Jan 19, 2023

    Leukemia, Acute, AML, Adult, ALL, Adult Trial in Charlottesville (Palliative Care Visits)

    Recruiting
    • Leukemia, Acute
    • +3 more
    • Palliative Care Visits
    • Charlottesville, Virginia
      University of Virginia
    Apr 28, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    Apr 10, 2023

    AML, Adult Recurrent, MDS Trial in United States (LYT-200)

    Recruiting
    • AML, Adult Recurrent
    • MDS
    • Los Angeles, California
    • +13 more
    Apr 12, 2023

    MDS, Acute Myeloid Leukemia Trial in New Haven (AG-120, Nivolumab)

    Withdrawn
    • Myelodysplastic Syndromes
    • Acute Myeloid Leukemia
    • New Haven, Connecticut
      Yale Cancer Center
    Jan 6, 2022

    High Risk Myelodysplastic Syndrome Trial in Houston (Guadecitabine)

    Active, not recruiting
    • High Risk Myelodysplastic Syndrome
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 2, 2022

    High Risk Myelodysplastic Syndrome, IPSS Risk Category Intermediate-1, Myelodysplastic Syndrome Trial in Houston (Azacitidine,

    Active, not recruiting
    Has Results
    • High Risk Myelodysplastic Syndrome
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 11, 2022

    Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

    Recruiting
    • Myelodysplastic Syndrome
    • +2 more
    • Granulocyte Colony-Stimulating Factor(G-CSF)
    • +5 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Jul 11, 2022

    AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in United States (APG-115, 5-azacitidine)

    Recruiting
    • AML
    • +6 more
    • Gilbert, Arizona
    • +7 more
    Jul 8, 2022

    MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Acute Myeloid Leukemia
    • Adelaide, Australia
    • +11 more
    Oct 13, 2022

    Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in

    Recruiting
    • Acute Myeloid Leukemia
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 7, 2022

    Recurrent Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Chronic Myelomonocytic Leukemia Trial

    Recruiting
    • Recurrent Chronic Myelomonocytic Leukemia
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 21, 2022

    MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)

    Active, not recruiting
    • Myelodysplastic Syndromes (MDS)
    • Acute Myelogenous Leukemia (AML)
    • low dose 5'-azacitidine
    • Basking Ridge, New Jersey
    • +6 more
    Dec 1, 2022

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, High Risk

    Recruiting
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +5 more
    • Gemtuzumab Ozogamicin
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

    Active, not recruiting
    • Leukemia
    • +7 more
    • Boston, Massachusetts
    • +10 more
    Jan 19, 2023